Search clinical trials for: lenalidomide, bendamustine, rituximab
Total 4143 results
-
CephalonCompletedMultiple MyelomaUnited States
-
Hoffmann-La RocheCompletedLymphomaUnited States, Italy, Korea, Republic of, Australia, Canada, Czechia, Spain, United Kingdom, France, Germany, Hungary, Turkey, Netherlands
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkCompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
BeiGeneActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, China, Taiwan, Belgium, France, United Kingdom, Spain, New Zealand, Australia, Czechia, Italy, Poland, Russian Federation, Sweden, Austria
-
Novartis PharmaceuticalsTerminatedLymphoma, FollicularUnited States, Belgium, Italy, Hong Kong, Austria, Germany, Japan, Russian Federation, United Kingdom, Canada, Slovakia, Poland, Ukraine, Puerto Rico, Greece, France, Argentina
-
Seoul National University HospitalCompletedNon-hodgkin Lymphoma,B CellKorea, Republic of
-
CephalonCompleted
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
Georgetown UniversityGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Columbia UniversityCompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaCanada, United States
-
Hoffmann-La RocheActive, not recruitingChronic Lymphocytic Leukemia (CLL)United States, Italy, Australia, Spain, France
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedLeukemiaIsrael, United States, Australia, Belarus, Brazil, Canada, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Singapore
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
Gruppo Italiano Studio LinfomiUnknown
-
Memorial Sloan Kettering Cancer CenterCephalonCompletedLymphoma | Hodgkin's DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; CephalonTerminatedBrain MetastasesUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
German Breast GroupCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Non-Hodgkin's LymphomaItaly
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Spain, Belgium, Austria, Czechia, Australia, Italy, Japan, Hungary, United Kingdom, Taiwan, Turkey, Germany, Canada, France, Israel, Poland, Croatia, Korea, Republic of, Ireland, Russian Federation, Singapore, Sw...
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
Cantonal Hospital of St. GallenCelgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...Completed
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.CompletedT-cell LymphomaFrance
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
Second Affiliated Hospital of Soochow UniversityEnrolling by invitationDiffuse Large B-cell LymphomaChina
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's LymphomaJapan
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNon-Hodgkin Lymphoma by Clinical CourseChina
-
German CLL Study GroupGilead Sciences; Novartis PharmaceuticalsCompletedChronic Lymphocytic LeukemiaGermany
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
Novartis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCGlaxoSmithKline; Novartis; CephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedNon-Hodgkin's Lymphoma | Indolent Non-follicularItaly
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Canada, Puerto Rico
-
M.D. Anderson Cancer CenterNational Comprehensive Cancer Network; CephalonCompleted
-
SymBio PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedLymphoma, Non-HodgkinUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedBendamustine | Conditioning Therapy | Autologous Stem Cell Transplant | Aggressive Non Hodgkin's LymphomaSpain